Wall Street brokerages expect HCP, Inc. (NYSE:HCP) to report earnings per share (EPS) of $0.46 for the current quarter, according to Zacks. Four analysts have made estimates for HCP’s earnings, with estimates ranging from $0.45 to $0.48. HCP reported earnings of $0.32 per share during the same quarter last year, which would suggest a positive year over year growth rate of 43.8%. The firm is scheduled to announce its next earnings results on Tuesday, November 7th.

On average, analysts expect that HCP will report full year earnings of $1.92 per share for the current fiscal year, with EPS estimates ranging from $1.90 to $1.96. For the next financial year, analysts expect that the firm will report earnings of $1.94 per share, with EPS estimates ranging from $1.86 to $2.05. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that follow HCP.

HCP (NYSE:HCP) last released its quarterly earnings results on Tuesday, August 1st. The real estate investment trust reported $0.48 EPS for the quarter, topping the consensus estimate of $0.47 by $0.01. The business had revenue of $458.90 million during the quarter, compared to analyst estimates of $456.29 million. HCP had a net margin of 32.16% and a return on equity of 9.96%. The company’s quarterly revenue was down 14.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.71 earnings per share.

A number of analysts recently commented on the company. Morgan Stanley lowered their price objective on HCP from $31.00 to $29.00 and set an “equal weight” rating for the company in a research report on Monday. Bank of America Corporation lowered HCP from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $33.00 to $31.00 in a research report on Friday, September 22nd. KeyCorp reiterated a “hold” rating on shares of HCP in a research report on Sunday, September 17th. BMO Capital Markets reiterated a “hold” rating and issued a $32.00 price objective on shares of HCP in a research report on Wednesday, September 6th. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $30.00 price objective on shares of HCP in a research report on Tuesday, August 22nd. Three analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have given a buy rating to the company. HCP has an average rating of “Hold” and an average price target of $32.41.

HCP (NYSE HCP) opened at 27.66 on Thursday. The stock’s 50 day moving average is $29.61 and its 200 day moving average is $30.98. The company has a market cap of $12.97 billion, a price-to-earnings ratio of 18.85 and a beta of 0.38. HCP has a 52-week low of $27.47 and a 52-week high of $36.16.

Several large investors have recently added to or reduced their stakes in the company. Lord Abbett & CO. LLC lifted its holdings in shares of HCP by 1.7% during the 2nd quarter. Lord Abbett & CO. LLC now owns 119,300 shares of the real estate investment trust’s stock valued at $3,813,000 after purchasing an additional 2,000 shares in the last quarter. Toronto Dominion Bank lifted its holdings in shares of HCP by 25.6% during the 2nd quarter. Toronto Dominion Bank now owns 158,731 shares of the real estate investment trust’s stock valued at $5,072,000 after purchasing an additional 32,365 shares in the last quarter. Cetera Investment Advisers bought a new position in shares of HCP during the 2nd quarter valued at about $208,000. Advisory Services Network LLC lifted its holdings in shares of HCP by 4.1% during the 2nd quarter. Advisory Services Network LLC now owns 3,782 shares of the real estate investment trust’s stock valued at $121,000 after purchasing an additional 150 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd lifted its holdings in shares of HCP by 106.5% during the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 27,111 shares of the real estate investment trust’s stock valued at $867,000 after purchasing an additional 13,985 shares in the last quarter. Institutional investors and hedge funds own 89.60% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/09/28/zacks-brokerages-expect-hcp-inc-hcp-to-post-0-46-eps.html.

About HCP

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Get a free copy of the Zacks research report on HCP (HCP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCP (NYSE:HCP)

Receive News & Stock Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related stocks with our FREE daily email newsletter.